Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Updated on: May 17,2024
3

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Updated on:May 17,2024
3
